EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
146 hedge funds and large institutions have $515M invested in Eagle Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
146
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$11.8M | |
| 2 | +$9.73M | |
| 3 | +$6.28M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$5.16M |
| 5 |
BlackRock
New York
|
+$4.31M |
Top Sellers
| 1 | -$18.8M | |
| 2 | -$8.01M | |
| 3 | -$5.31M | |
| 4 |
Two Sigma Advisers
New York
|
-$3.62M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$3.55M |